DRG Instruments GmbH
Booth number: Z6.E30
www.drg-diagnostics.de
About us
DRG – More than 50 Years of Innovative Diagnostics
The DRG group, with locations across globally, is a leading manufacturer and supplier of ELISAs for clinical diagnostics and research with distributors in over 120 countries.
DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for immunoassays and clinical chemistry, and supplier of chemiluminescent immunoassay technology With decades of experiences in ELISAs and automations, DRG provides customers with the highest quality and reliable products and best of services to advance solutions in the diagnostics and research world.
In 2021 BioCheck Inc. (CA, USA) acquired DRG Together with the DRG group, the Company’s goal is to provide timely information so that treatment can be initiated earlier and efficacy analyzed sooner to better the long-term outcomes.
DRG is an EN ISO 13485:2016 certified company and operates in compliance with FDA 21 CFR 820 Quality System Regulation.
Address
Frauenbergstr. 18
35039 Marburg
Germany
Phone: +49 6421 17000
Products & Services
DRG is specialized in the development and production of innovative immunoassays, for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function, iron metabolism, saliva diagnostics, infectious diseases and many more.
DRG is also the manufacturer of the DRG:HYBRiD-XL, a fully automated analyzer for immunoassays and clinical chemistry. The assay menu includes routine as well as niche parameters. Recently DRG has launched a new product group for the fully automatic determination of antibiotic TDMs for DRG:HYBRiD-XL.
Furthermore, DRG & BioCheck are excited to add to the automation portfolio with CLIA device ImmuF6 and its associated menu of reagent assays, and ELISA devices, DYNEX DSX and DS2 instruments, with an addition of automation technical service to better customer’s with the ELISA automation experience.